TNDM Q4 2021 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$210M+24.9% YoY

Gross Profit

$114M54.2% margin

Operating Income

$13M6.1% margin

Net Income

$11M5.1% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

+16.9%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$14M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$905M

Total Liabilities

$472M

Stockholders' Equity

$433M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$210M	$168M	+24.9%
Gross Profit	$114M	$91M	+25.6%
Operating Income	$13M	$19M	-31.7%
Net Income	$11M	$17M	-36.4%

Geographic Segments

UNITED STATES

$161M77%

Non-US

$49M23%